Suchergebnisse - "Xu, Binghe"

PubPharm (520)

91

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer

enthalten in: JAMA network open | 2022

von Mo, H. | Yan, X. | Zhao, F. | +11

92

GLORIA : phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer

enthalten in: Future oncology (London, England) | 2022

von Rugo, H. | Cortes, J. | Barrios, C. | +9

93

Breast cancer : an up-to-date review and future perspectives

enthalten in: Cancer communications (London, England) | 2022

von Hong, R. | Xu, B.

94

Development and External Validation of a Clinical Nomogram for Individually Predicting Survival of Metaplastic Breast Cancer

enthalten in: Clinical breast cancer | 2022

von Wang, J. | Li, Q. | Luo, Y. | +8

95

Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first-line options for HER2-positive relapsed or metastatic breast cancer

enthalten in: Cancer innovation | 2022

von Guan, X. | Ma, F. | Xu, B.

96

Whole-genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer

enthalten in: Clinical and translational medicine | 2022

von Gao, Y. | Zhao, H. | An, K. | +15

97

Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple-negative breast cancer : A prospective cohort study with propensity-matched analysis

enthalten in: International journal of cancer | 2022

von Xiu, M. | Zhang, P. | Wang, X. | +9

98

A Phase 1 Study of SHR6390, A Cyclin-dependent Kinase 4/6 Inhibitor in Patients with Advanced Breast Cancer

enthalten in: ResearchSquare.com | 2022

von Zhang, P. | Xu, B. | Gui, L. | +6

99

Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies : real-world data in the Han population

enthalten in: Chinese medical journal | 2022

von Mo, H. | Ma, F. | Li, Q. | +7

100

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients

enthalten in: Cancer medicine | 2022

von Liu, B. | Yi, Z. | Guan, Y. | +10